SCIENCE & EVIDENCE
Adipose tissue is the body’s fat tissue. Its cells sit within a network of small vessels and supporting matrix. Liposmart’s scientific approach considers this whole environment when preparing the tissue.
WHY ARCHITECTURE MATTERS
Adipose tissue combines cellular, structural and signalling functions. Three concepts help explain the rationale for studying tissue preservation.
The stromal vascular niche is the local environment around small blood vessels. Endothelial cells line the vessels; perivascular cells sit alongside them. Other stromal cells and supporting matrix complete the surrounding tissue.
MFAT research examines these spatial relationships alongside cellular composition. Liposmart’s laboratory reports bring that question to its processed samples through paired fluorescence imaging.
Read the foundational work ↓The extracellular matrix is the supporting network around cells. Its structure provides physical and chemical cues. Cells sense these cues and turn them into biological responses—a process called mechanotransduction.
Foundational experiments show that matrix elasticity can influence stem-cell behaviour in culture. This explains why structure deserves attention alongside the cells themselves.
Explore matrix biology ↓Cells communicate by releasing soluble factors and extracellular vesicles. Together, these released molecules are called the secretome; their local effects are described as paracrine signalling.
Laboratory studies of MFAT investigate this molecular activity alongside tissue composition. They provide a biological rationale to test in well-designed clinical studies.
Explore the signalling research ↓These concepts describe the scientific rationale. The cited studies identify the experimental system and the scope of each finding.
THREE TERMS. DIFFERENT MEANINGS.
MFAT, SVF and SVN describe different aspects of adipose-tissue science: a tissue preparation, a cellular fraction and an organised microenvironment.
Microfragmented adipose tissue is mechanically processed fat that retains tissue clusters. Research examines the cellular and structural features within those clusters.
Explore the MFAT research ↗Stromal vascular fraction describes a heterogeneous cell population obtained from adipose tissue, often through enzymatic digestion. It differs from a tissue preparation with its native three-dimensional structure.
Read the comparative study ↗The stromal vascular niche describes relationships among microvessels, neighbouring stromal cells and extracellular matrix. It is a way of understanding tissue organisation.
Examine the Liposmart images ↗The wider scientific framework also discusses stress-enduring MUSE cells, telocyte networks and extracellular vesicles as topics in tissue biology. Their specific presence, preservation and activity in a Liposmart preparation require dedicated assays.
The Liposmart reports shown here assess LIVE/DEAD appearances and selected vascular, adipocytic and macrophage-associated markers. They do not quantify MUSE cells, establish telocyte-network preservation, or measure exosome yield.
LIPOSMART · ORIGINAL LABORATORY MATERIAL
Paired microscopy compares original lipoaspirate with the corresponding Liposmart product. The original reports and authors are listed in the reference library.
VASCULAR CADHERIN · CD31
The paired fluorescence images show vascular-marker staining in the original and processed tissue. The source report describes preservation of fine vascular structures following Liposmart processing.
Second sample series · slide 3 · shared 27 April 2023
Representative microscopy illustrates the sampled fields. The reports do not establish a numerical viability rate, prove clinical efficacy, or identify every cell population in the tissue.
Open the original series ↗The 21 September 2023 INBB report describes the microscopy methods and representative findings in Liposmart-processed human adipose tissue.
View report details ↓READ THE DEVELOPMENT IN CONTEXT
These materials describe particular sampled preparations. They help document development and guide the questions for further characterisation.
The early report noted heterogeneous starting tissue and membrane disruption in some configurations, particularly after repeated 700 μm passes. The authors proposed pressure as a possible contributor and recommended repeat testing.
This observation concerns an early development series; it should not be generalised to every current configuration. The documents reviewed do not establish whether a specific design change resolved the proposed cause.
Read the original development report ↗The accompanying laboratory correspondence reported similar viability appearances and well-retained fine vascular structures in the second paired sample. The seven-slide attachment is the source of the microscopy viewer above.
The accompanying correspondence dates the sharing of this series to 27 April 2023. The PDF itself has no internal date.
Read the paired microscopy series ↗The later dated report describes the imaging methods and representative tissue findings. It provides laboratory context alongside the paired series, rather than a clinical trial or a numerical viability validation.
Read the dated laboratory report ↗FROM BIOLOGY TO PROCESSING
Liposmart uses mechanical processing and washing to prepare autologous adipose tissue. The documented pathways depend on the selected system.
Compare all four configurations ↗Saline washing separates blood, free oil and processing fluid from the collected tissue. This is a preparation step, distinct from enzymatic cell isolation.
The range includes 700 μm tissue filtration, with an additional 1,200 μm filter in UFAT 120 mL, Augment 275 mL and Pure Flow. These numbers specify filter apertures.
The processed material remains an adipose-tissue preparation. It should be distinguished from an isolated cell suspension, an expanded cell product, or a purified extracellular-vesicle preparation.
THE WIDER MFAT FIELD
Clinical studies ask whether laboratory observations translate into benefits for patients. Results depend on study design, preparation and the condition being investigated.
Published findings are mixed. These selected studies provide context for the research field and used other MFAT systems; neither is a Liposmart clinical trial.
The authors reported improvements in pain and function with MFAT compared with saline. The trial was partially blinded and allocated patients among three groups.
Read the study summary ↓Both groups improved, with no statistically significant between-group differences. The blinded trial did not show superiority of MFAT over saline.
Read the study summary ↓The evidence supports continued, indication-specific research. Laboratory preservation and symptom improvement are different outcomes; cartilage regeneration and lasting treatment benefits require their own clinical evidence.
READ THE ORIGINAL SOURCES
Selected reports and peer-reviewed papers, with the study type, processing system and scope made visible.
Showing 14 sources
The four-page report sent on 18 February 2023 compares unprocessed tissue with washing and filtration configurations. The authors noted sample heterogeneity and membrane disruption, particularly after repeated 700 μm passes, and proposed further testing.
An exploratory development series. Pressure was proposed as a possible contributor; the report does not establish a cause or validate the current product range. Its observations should be read alongside the later sample series.
The report dated 21 September 2023 describes LIVE/DEAD assessment and fluorescence imaging of original lipoaspirate and corresponding processed tissue. Representative images support the presence of viable cells and organised vascular structures.
Laboratory characterisation; the report does not provide a clinical outcome trial or a validated percentage viability result.
Seven slides compare original lipoaspirate with Liposmart-processed tissue using LIVE/DEAD, vascular cadherin/CD31 and perilipin/CD68 staining. The images presented on this page come from this series.
Shared by Carlo Ventura on 27 April 2023, as established by the accompanying correspondence. Representative fields, without a quantified comparison across a reported donor cohort.
Experiments with cultured mesenchymal stem cells showed that matrix elasticity can influence lineage specification. This is a foundation for understanding how the physical microenvironment affects cell behaviour.
A cell-culture study of matrix mechanics; it does not establish an optimal Liposmart preparation or demonstrate regeneration in patients.
Describes vascular stroma and pericyte-like elements in mechanically processed adipose tissue, using histology, immunohistochemistry and cellular analyses.
The study used Lipogems. It is foundational MFAT research, rather than a study of Liposmart.
Conditioned media from microfragmented tissue and derived stromal cells were studied in endothelial-cell and macrophage models. The results support investigation of paracrine mechanisms.
In vitro work using Lipogems; laboratory activity is not a measured treatment effect in patients.
Compared mechanically processed tissue with enzymatically derived stromal vascular fraction. The authors reported differences in pericyte content and the release of growth factors and cytokines under experimental conditions.
The study used a different processing system. Its numerical findings should not be transferred to Liposmart.
Histology, cellular analysis, proteomics and extracellular-vesicle microRNA profiling examined the effects of microfragmentation. The authors found reduced blood elements with maintained structural and stromal components.
Research using Lipogems. Secretome profiling characterises released molecules; it does not quantify Liposmart exosome yield or clinical potency.
A retrospective comparison included 76 patients with follow-up data. Both groups reported improved pain and function, with no significant difference between the groups.
Nonrandomised, with different follow-up durations and no saline control. MFAT was prepared with Lipogems; this is not a Liposmart trial.
Seventy-five patients were randomised among MFAT, corticosteroid and saline. The authors reported better pain and function outcomes with MFAT than saline over one year.
A partially blinded trial using a different system. It supports a clinical research question, without establishing a Liposmart-specific treatment result.
In a blinded randomised trial of 120 patients, both groups improved, with no statistically significant between-group differences at the assessed time points.
The trial did not demonstrate superiority over saline. It studied another MFAT system and helps place positive studies in context.
Reviews how cytoskeletal mechanics and extracellular matrix participate in cellular sensing and biological responses. Provides a framework for understanding the physical context surrounding cells.
A review of mechanobiology across experimental systems, published online in December 2022 and collected in January 2023. It does not test Liposmart or establish an optimal processing pressure or tissue stiffness.
Examines relationships among mechanical dynamics, molecular signalling and biophotonic activity, including research on photobiomodulation and tissue-resident stem cells.
A broader research perspective. It is not a study of Liposmart processing, a demonstration of biophotonic effects in UFAT, or clinical validation of the device.
An institutional research abstract introduces the UFAT concept in the context of adipose-tissue processing and the stromal vascular niche, alongside the laboratory’s broader research programme.
A conference contribution rather than a full product-validation study. It does not provide the assay methods, cohort data or quantitative endpoints needed to substantiate product-specific MUSE-cell or exosome claims.
No sources match this search. Try another topic or select All sources.
Selection reviewed 26 October 2026. This is a curated reading list. Drive-hosted originals retain their existing access permissions.
THE LANGUAGE OF TISSUE SCIENCE
The local environment around small blood vessels, including neighbouring cells and extracellular matrix. It describes an organised tissue context.
MFAT means microfragmented adipose tissue: fat mechanically prepared into smaller tissue clusters. UFAT means Unified Fluid Adipose Tissue, the term used in Liposmart’s scientific concept for the prepared tissue. UFAT 120 mL also names one of the devices; the device and the tissue are distinct.
The extracellular matrix surrounds and supports cells. Mechanotransduction is the process through which cells sense physical cues and convert them into biological responses.
The secretome comprises molecules released by cells, including soluble proteins and extracellular vesicles. Exosomes are one class of vesicles; finding vesicle-associated signals does not by itself establish a purified exosome product.
Laboratory characterisation measures features of samples, such as structure, markers or cell viability. Clinical studies evaluate outcomes in people. Each answers a different question and requires its own methods and controls.
GO DEEPER WITH THE TEAM
Discuss the tissue science, product documentation and physician education available for your practice or distribution team.
